1. Home
  2. REVB vs OFAL Comparison

REVB vs OFAL Comparison

Compare REVB & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.48

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Logo OFA Group Ordinary Shares

OFAL

OFA Group Ordinary Shares

HOLD

Current Price

$0.35

Market Cap

1.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
OFAL
Founded
2020
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.7M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
REVB
OFAL
Price
$0.48
$0.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.4K
★ 14.1M
Earning Date
11-05-2026
07-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.68
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $716,885.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 254.88
52 Week Low
$0.47
$0.08
52 Week High
$2.32
$3.79

Technical Indicators

Market Signals
Indicator
REVB
OFAL
Relative Strength Index (RSI) 22.76 37.64
Support Level $0.47 $0.19
Resistance Level $1.21 $0.72
Average True Range (ATR) 0.06 0.06
MACD -0.02 -0.01
Stochastic Oscillator 2.06 6.94

Price Performance

Historical Comparison
REVB
OFAL

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

About OFAL OFA Group Ordinary Shares

OFA Group provides interior design, fit-out, project management and application services in Hong Kong for commercial and residential buildings. Its interior design services include consultation, conceptualized designs, layout plans, detailed design drawings and advice on budgetary considerations, space utilization, materials, fittings, furniture, appliances and other items. Its fit-out services include the installation of protective materials, partition walls, windows, decorative fittings, furniture, fixtures, plumbing systems, switches, power outlets, telephone wiring, computer outlet covers and other electrical and wiring works. The Group is transitioning from a project-based model to a subscription-based model for AI tools, real estate development and senior care infrastructure.

Share on Social Networks: